Antibiotic News and Research

RSS

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.

Study finds entry point for curbing the evolution of antibiotic resistance

The team of Professor Tobias Bollenbach from the Institute for Biological Physics at the University of Cologne has published a study on a new approach to improving the effectiveness of antibiotics in bacterial infections.

24 Jun 2020

New findings provide a glimpse of daunting experiences faced by hospitals in fight against COVID-19

Healthcare epidemiologists report using unprecedented methods in response to the unique circumstances resulting from the COVID-19 pandemic, according to the results of a new study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America (SHEA).

24 Jun 2020

Study: Increased use of human antibiotics on rice crops may fuel antibiotic resistance

Farmers in parts of Asia are spraying antibiotics deemed "critical" for human medicine on rice crops, raising fears they may be fuelling antibiotic resistance, say researchers.

23 Jun 2020

UQ superbug drug discoveries will be fast-tracked under international research deal

Antibiotics discovered at The University of Queensland will be fast-tracked under an US$11 million international research deal.

22 Jun 2020

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

A new study from Belgian researchers shows that antiviral drug Favipiravir could have a weak effect against the dreaded novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as seen in hamster models. However, the study also finds there is no efficacy of the much-touted drug Hydroxychloroquine.

22 Jun 2020

Oral antibiotic therapy can effectively treat infections in people who inject illicit drugs

People who inject illicit drugs can develop potentially deadly infections of the heart, blood, joints and soft tissues.

17 Jun 2020

Antibiotic X-206 effective against SARS-CoV-2 in vitro

The current study published on the preprint server bioRxiv aims to understand how these compounds affect SARS-CoV-2 in vitro. The researchers from Aarhus University in Denmark examined 11 natural PEIs, with a single synthetic analog, screening them for inhibitory activity against the CPE of SARS-CoV-2 infecting cultured cells with overexpression of TMPRSS2, a serine protease that is instrumental in cleaving the spike protein of the virus.

16 Jun 2020

A new, daily home-monitoring program for patients presumed COVID-19 positive

How do you monitor patients who have COVID-19 symptoms but are not ill enough to come to the emergency department? And how do you help those patients feel cared about and less frightened while convalescing at home?

16 Jun 2020

Australian program helps keep young cancer patients with a fever at home

An Australian program that avoids hospital admission for some young cancer patients with a fever is helping to ease pressure on the UK health system during the COVID-19 crisis.

16 Jun 2020

Wastewater should be improved to eliminate antibiotic resistance, says Örebro University expert

Over a three-year period, Faisal Ahmad Khan and his fellow researchers have taken samples from various sites along the River Svartån and in the Lake Hjälmaren – including both upstream and downstream the river from the city centre; in Hemfjärden where the river flows into the lake; as well as in the water by the treatment plant in Örebro.

16 Jun 2020

Why improved pneumonia diagnosis is needed now more than ever

News-Medical speaks to Dr. William La Via about why improved pneumonia diagnosis is vital, especially in the wake of the COVID-19 pandemic.

16 Jun 2020

Early genetic rescue may be a potential therapy in autism spectrum disorder

A mouse study by Craig Powell, M.D., Ph.D., and colleagues suggests that early genetic rescue may be a potential therapy in autism spectrum disorder or ASD.

16 Jun 2020

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Cocaine is a highly addictive drug - some people are unable to walk away from it after just one use. And once addicted, users can lose control of their lives.

15 Jun 2020

Study recommends "microbial Noah's ark" to protect long-term health of humanity

A new study finds that proposal to create a "microbial Noah's ark" to protect the long-term health of humanity is feasible and should move forward into a pilot project phase, that would include installing infrastructure to store microbes in a site such as Norway or Switzerland and a collaboration for collecting samples all over the world.

12 Jun 2020

Expanding flu vaccine coverage could reduce inappropriate antibiotic prescribing

Up to 76 percent of all outpatient antibiotic prescriptions in the United States may be inappropriate, with peak prescribing associated with the flu season.

10 Jun 2020

Study identifies potential high-risk virulent clones circulating in European hospitals

UAB researchers, based on a collection of clinical isolates from several countries, have established a link between the cell-to-cell communication system (the quorum sensing) and the virulence and resistance phenotypes in Stenotrophomonas maltophilia.

10 Jun 2020

Phenothiazine derivatives show high potential for use in photodynamic therapy

A group on organic compounds under Professor Ivan Stoikov's guidance has been working on phenothiazine derivatives at Kazan Federal University since 2016.

9 Jun 2020

Old antibiotic may be a powerful new tool against deadly superbug

USC researchers have discovered that an old antibiotic may be a powerful new tool against a deadly superbug, thanks to an innovative screening method that better mimics conditions inside the human body.

8 Jun 2020

Discovery of new killing mechanism could help design improved teixobactin-based drugs

Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin - a new class of potent natural antibiotic capable of killing superbugs.

5 Jun 2020

George Mason researcher examining the use of Brilacidin for treatment of coronavirus infections

Aarthi Narayanan, Assistant Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections.

5 Jun 2020

Antibiotic News and Research

Further Reading

Study finds entry point for curbing the evolution of antibiotic resistance

New findings provide a glimpse of daunting experiences faced by hospitals in fight against COVID-19

Study: Increased use of human antibiotics on rice crops may fuel antibiotic resistance

UQ superbug drug discoveries will be fast-tracked under international research deal

Favipiravir has weak effect on SARS-CoV-2 and Hydroxychloroquine none at all in hamster model

Oral antibiotic therapy can effectively treat infections in people who inject illicit drugs

Antibiotic X-206 effective against SARS-CoV-2 in vitro

A new, daily home-monitoring program for patients presumed COVID-19 positive

Australian program helps keep young cancer patients with a fever at home

Wastewater should be improved to eliminate antibiotic resistance, says Örebro University expert

Why improved pneumonia diagnosis is needed now more than ever

Early genetic rescue may be a potential therapy in autism spectrum disorder

Temple researchers receive $1.77M grant to explore therapy for cocaine addiction

Study recommends "microbial Noah's ark" to protect long-term health of humanity

Expanding flu vaccine coverage could reduce inappropriate antibiotic prescribing

Study identifies potential high-risk virulent clones circulating in European hospitals

Phenothiazine derivatives show high potential for use in photodynamic therapy

Old antibiotic may be a powerful new tool against deadly superbug

Discovery of new killing mechanism could help design improved teixobactin-based drugs

George Mason researcher examining the use of Brilacidin for treatment of coronavirus infections

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News